ROLANDO MENDOZA LOPEZ, OD
Optometrist in CARMEL, Indiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
ROLANDO MENDOZA LOPEZ, OD reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 186 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 186
- Part D claims, 2023
- 70%
- generic prescribing
- $287.99
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
ROLANDO MENDOZA LOPEZ, OD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
100 Top 7% higher than 93% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about ROLANDO MENDOZA LOPEZ, OD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Indiana
How Optometrist compares to other specialties among Indiana providers
Optometrist share within Indiana
Optometrist is one of the more visible NUCC categories in Indiana
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
ROLANDO MENDOZA LOPEZ, OD's 2023 MIPS final score plotted against the Optometrist national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Optometrist) — 100/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Optometrist US NPIs
100/100 MIPS final score — 16.9 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Optometrist. Quality dim: 100.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ROLANDO MENDOZA LOPEZ, OD appears in the CMS NPPES registry as a Optometrist provider holding OD credentials at 1320 CITY CENTER DR STE 150, CARMEL, IN, 46032, with a listed phone of (317) 846-4223. NPI 1053981290 was issued on 06/29/2021. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MENDOZA LOPEZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 186 prescription claims written by this provider, covering 109 Medicare beneficiaries and totaling roughly $32K in drug spend, split 30% brand-name and 70% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 100), compared with the national average of 83.1.
Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1053981290 |
|---|---|
| Specialty | Optometrist |
| Credentials | OD |
| Gender | Male |
| NPI Issued | 06/29/2021 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ROLANDO MENDOZA LOPEZ, OD's current license status, disciplinary history, and board certifications with the Indiana Medical Licensing Board in Indiana before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where ROLANDO MENDOZA LOPEZ, OD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROLANDO MENDOZA LOPEZ, OD. Source: openpaymentsdata.cms.gov.
Total received
$288
Largest payer
Bausch & Lomb Americas Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
30% brand-name claims vs 70% generic, on 186 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 265
- Total Day Supply
- 6,240
- Brand vs Generic
- 30% brand / 70% generic
- Brand Drug Cost
- $30K
- Generic Drug Cost
- $3K
Patient Demographics
- Average Patient Age
- 72.0 years
- Avg HCC Risk Score
- 1.45
- Gender Split
- 70% female / 30% male
- Age Distribution
- <65: 18, 65-74: 50, 75-84: 29, 85+: 12
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What ROLANDO MENDOZA LOPEZ, OD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Erythromycin
Erythromycin
45 claims
- Neomycin-Polymyxin…
Neomycin-Polymyxin-Dexameth
21 claims
- Lumigan
Lumigan
20 claims
- Latanoprost
Latanoprost
19 claims
- Prednisolone Acetate 14
Prednisolone Acetate
14 claims
| Drug | Claims |
|---|---|
| Erythromycin Erythromycin Base | 45 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 21 |
| Lumigan Bimatoprost | 20 |
| Latanoprost | 19 |
| Prednisolone Acetate | 14 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How ROLANDO MENDOZA LOPEZ, OD fits within the Optometrist landscape nationally.
ROLANDO MENDOZA LOPEZ, OD's 186 claims are below the specialty average of 257.
Nearby Optometrist Providers in Indiana
Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as MENDOZA LOPEZ.
Compare Optometrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Indiana
Frequently Asked Questions
What is ROLANDO MENDOZA LOPEZ, OD's specialty? ▼
How much does ROLANDO MENDOZA LOPEZ, OD prescribe under Medicare Part D? ▼
What is ROLANDO MENDOZA LOPEZ, OD's Medicare quality score? ▼
Where is ROLANDO MENDOZA LOPEZ, OD located? ▼
What is ROLANDO MENDOZA LOPEZ, OD's NPI number? ▼
Does ROLANDO MENDOZA LOPEZ, OD prescribe more brand-name or generic drugs? ▼
How many Optometrist providers are there in the US? ▼
What drugs does ROLANDO MENDOZA LOPEZ, OD prescribe most often? ▼
Does ROLANDO MENDOZA LOPEZ, OD accept Medicare? ▼
How can I verify ROLANDO MENDOZA LOPEZ, OD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology